The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.

Beijing Gene+ Technology raised the cash in a round, reportedly the largest closed by a precision medicine company in China, led by genome sequencing firm BGI.

The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.

Prescription skincare product supplier Curology has closed a $15m series B round led by the Advance Publications-backed Advance Vixeid Partners.

Baidu and SBCVC both invested in a $32.4m round for the medical appointment booking platform, with the latter also backing a $14.6m round for care management platform Kyee.

Battery Ventures led the home care software provider's latest round, joining an investor base that includes Qualcomm, McKesson and Cambia Health.

The biotech company is seeking up to $45m from an initial public offering that will be conducted in April or May 2017, and is currently raising more funding.

Generali Insurance, Miele and Barmer Gek are among the limited partners that backed the first close of the fund, which is expected to reach $135m in size.

UT Horizon Fund has participated in a $2m series A for medical device manufacturer Alafair Biosciences.

Lundbeck-backed Iconic Therapeutics, which aims to apply tissue factor biology to retinal disease and cancer treatments, has now raised $80m altogether.